What is the role of autoimmunity in multiple sclerosis?

被引:0
|
作者
Chabas, D [1 ]
Liblau, R
机构
[1] Grp Hosp Pitie Salpetriere, Federat Neurol, F-75634 Paris, France
[2] Grp Hosp Pitie Salpetriere, Lab Immunol Cellulaire, F-75013 Paris, France
[3] Grp Hosp Pitie Salpetriere, INSERM, CJF 97 11, F-75013 Paris, France
来源
PATHOLOGIE BIOLOGIE | 2000年 / 48卷 / 01期
关键词
autoimmunity; immunosuppressant; multiple sclerosis;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
A number of evidences indicate that an antigen-specific immune reaction is responsible for the formation and/or the maintenance of multiple sclerosis (MS) lesions. This disease is characterized by the following: 1), an infiltration of the white matter of the brain and spinal cord by inflammatory cells; 2), the T and B lymphocytes, present in the lesions or in the cerebrospinal fluid of patients, show signs of activation; i.e., the classic IgG oligoclonal bands of the cerebrospinal fluid (activation of B lymphocytes) and the presence of activation markers on the surface of the T lymphocytes; 3), the presence of an association, and a linkage between the disease and the genes of the HLA complex. The HLA molecules are implicated in the presentation of the antigen to the T lymphocytes; 4), finally, A should be noted that the therapeutic approaches aimed at reducing (immunosuppressants) or at modulating (beta-interferon, copolymer 1) the immune responses have a positive effect on this disease, whereas those treatments which activate the immune system (gamma-interferon) have a negative effect. (C) Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:25 / 46
页数:22
相关论文
共 50 条
  • [1] Multiple Sclerosis and Autoimmunity: A Veiled Relationship
    Barkhane, Zineb
    Elmadi, Jalal
    Kumar, Lakshmi Satish
    Pugalenthi, Lakshmi Sree
    Ahmad, Mahlika
    Reddy, Sanjana
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
  • [2] Isoniazid in autoimmunity: a trigger for multiple sclerosis?
    Nourbakhsh, Bardia
    Stueve, Olaf
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2014, 7 (05) : 253 - 256
  • [3] Microvesicles: what is the role in multiple sclerosis?
    Carandini, Tiziana
    Colombo, Federico
    Finardi, Annamaria
    Casella, Giacomo
    Garzetti, Livia
    Verderio, Claudia
    Furlan, Roberto
    FRONTIERS IN NEUROLOGY, 2015, 6
  • [4] FcRL3 and multiple sclerosis pathogenesis:: Role in autoimmunity?
    Martinez, Alfonso
    Mas, Ana
    de las Heras, Virginia
    Bartolome, Manuel
    Arroyo, Rafael
    Fernandez-Arquero, Miguel
    de la Concha, Emilio G.
    Urcelay, Elena
    JOURNAL OF NEUROIMMUNOLOGY, 2007, 189 (1-2) : 132 - 136
  • [5] Humoral autoimmunity in multiple sclerosis
    Meinl, Edgar
    Derfuss, Tobias
    Krumbholz, Markus
    Proebstel, Anne-Katrin
    Hohlfeld, Reinhard
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2011, 306 (1-2) : 180 - 182
  • [6] The role of alemtuzumab in the development of secondary autoimmunity in multiple Sclerosis: a systematic review
    Jimenez-Sanchez, Sofia
    Maksoud, Rebekah
    Eaton-Fitch, Natalie
    Marshall-Gradisnik, Sonya
    Broadley, Simon A.
    JOURNAL OF NEUROINFLAMMATION, 2024, 21 (01)
  • [7] Microchimerism in autoimmunity and transplantation: potential relevance to multiple sclerosis
    Willer, CJ
    Sadovnick, AD
    Ebers, GC
    JOURNAL OF NEUROIMMUNOLOGY, 2002, 126 (1-2) : 126 - 133
  • [8] Autoimmunity in multiple sclerosis: study of a wide spectrum of autoantibodies
    Spadaro, M
    Amendolea, MA
    Mazzucconi, MG
    Fantozzi, R
    Di Lello, R
    Zangari, P
    Masala, C
    MULTIPLE SCLEROSIS, 1999, 5 (02): : 121 - 125
  • [9] Innate immune regulation of autoimmunity in multiple sclerosis: Focus on the role of Toll-like receptor 2
    Hossain, Md Jakir
    Tanasescu, Radu
    Gran, Bruno
    JOURNAL OF NEUROIMMUNOLOGY, 2017, 304 : 11 - 20
  • [10] Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective
    Jakimovski, Dejan
    Weinstock-Guttman, Bianca
    Ramanathan, Murali
    Dwyer, Michael G.
    Zivadinov, Robert
    VACCINES, 2020, 8 (01)